Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Sep 6, 2022; 10(25): 8837-8843
Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.8837
Table 1 Patients’ data and admissions from March to September 2016–2020
Parameter
2016
2017
2018
2019
2020
P
M9181921140.037262
F3671722
Mean age ± SD (range)52.0 ± 19.344 (30-87)47.0 ± 14.794 (19-77)45.0 ± 12.966 (25-67)46.0 ± 13.440 (25-74)52.0 ± 12.776 (26-85)0.243556
Total admission12242638360.022151
First onset AP11221526290.091681
Recurrent AP12111270.020791
Total admission1224263836
March-May681415210.16571
June-September6161223150.096081
First onset AP1122152629
March-May6871318
June-September51481311
Disease severity (n)0.92622
Mild816172925
Moderate37689
Severe11312
Median hospital stay (IQR)4.5 (2.0; 7.0)4.5 (3.0; 9.0)3.00 (1.25; 5.75)4 (2; 6)3.00 (2.00; 5.25)0.5403171
Table 2 Serum biochemistry results 2016–2020
Median parameter (IQR)1
2016
2017
2018
2019
2020
Overall P
Creatinine55.0 (50.5, 57.0)61.5 (51.5, 72.5)57.5 (54.0, 65.5)62 (53, 82)60.0 (54.0, 76.5)0.61261
eGFR90 (90, 90)90 (90, 90)90 (90, 90)90 (90, 90)90.0 (89.5, 90.0)0.447051
CRP45.5 (15.0, 185.0)57.50 (19.0, 212.75)65.0 (6.75, 93.00)6.0 (1.0, 30.5)6.50 (3.25, 13.75)0.00026951
Hb133 (125, 143)132.5 (125.5, 146.5)145.0 (136.0, 151.5)149 (136, 159)138.0 (127.5, 147.0)0.083811
White cell count7.00 (5.95, 11.70)12.05 (9.35, 14.45)10.30 (6.875, 15.35)10.2 (6.2, 13.0)10.7 (7.8, 12.4)0.21831
Amylase286.0 (112.25, 650.00)158 (103, 520)242.0 (204.0, 463.75)254 (137, 433)382.0 (102.5, 613.5)0.84971